Erudio Healtherudio.com
Myeloma congress
IMS 2027 Annual Meeting
Sep 29 – Oct 2, 2027 · New Delhi, India
Starts in 322 days
- Today · Nov 11
- Sep 29 – Oct 2Meeting
- Oct 9First reports likely
- Dates
- Sep 29 – Oct 2, 2027India Standard Time (New Delhi)
- Website
- myelomasociety.org ↗
- Organiser
- International Myeloma Society (IMS)
- Calendar
- Add to calendar
Trials at IMS 2027
No trial is placed here yet.
A trial is listed only when at least two public sources, from two different publishers, place its results or presentation at IMS 2027 Annual Meeting; each row says how many did.
What happens next
- Sep 29 – Oct 2: the meeting; the list fills as clinicians talk about it.
- After: reports on the trials discussed, every statement linked to its source.
Myeloma reports so far
The newest published reports on myeloma trials from other congresses.
- IMS 2026EXCALIBER-RRMMiberdomide plus daratumumab · relapsed or refractory multiple myeloma490 statements · 105 sources
- IMS 2026MELT-MMmezigdomide plus elranatamab plus dexamethasone · relapsed/refractory multiple myeloma54 statements · 13 sources
- ASCO 2026LINKER-AL2linvoseltamab · relapsed or refractory systemic light chain amyloidosis149 statements · 25 sources
Editions
| Edition | Dates | City |
|---|---|---|
| IMS 2027this page | Sep 29 – Oct 2, 2027 | New Delhi |
| IMS 2026 | Sep 23–26, 2026 | Glasgow |
| IMS 2025 | Sep 17–20, 2025 | Toronto |
| IMS 2024 | Sep 25–28, 2024 | Rio de Janeiro |
| IMS 2023 | Sep 27–30, 2023 | Athens |
| IMS 2022 | Aug 25–27, 2022 | Los Angeles |
| IMS 2021 | Sep 8–11, 2021 | Vienna |
| IMS 2019 | Sep 12–15, 2019 | Boston |
Next on the calendar
| Congress | Dates | City |
|---|---|---|
| SITC 2027 | Nov 3–7 | National Harbor, MD |
| ESMO Asia 2027 | Dec 3–5 | Singapore |
| SABCS 2027 | Dec 7–10 | San Antonio |
How a trial gets on this page
A trial is listed only when at least two public sources, from two different publishers, place its results or presentation at IMS 2027 Annual Meeting; each row says how many did. The list is rebuilt every six hours.Reports
Focused$750Standard$1,250Deep$1,950Pricing
Priced by size, licensed permanently for your organization's internal use, with MCP access for your AI agent. Organised by International Myeloma Society (IMS); Erudio is not affiliated with it.